Treatment efficacy of short-term IFN-2beta for chronic hepatitis

Treatment efficacy of short-term IFN-2beta for chronic hepatitis - GLSG,2005, Intron

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000208

Enrollment

Registered

2011-09-13

Start date

2005-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis C

Interventions

Intron (Interferon alpha 2b)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic hepatitis C positive test of HCV-RNA and more than 100KIU/ml of HCV-RNA load abnormal transaminase negative test of HBsAg

Exclusion criteria

Exclusion criteria: liver dysfunction with other causes Allergy to Interferon (IFN) during pregnancy Severe complication-especially poor hematopoiesis, renal, cardiac or respiratory function

Design outcomes

Primary

Measure	Time frame
HCV-RNA	—

Secondary

Measure	Time frame
transaminase	—

Countries

Japan

Contacts

Public ContactKen Sato

Gunma University Graduate School of medicine Department of Medicine and Molecular Science

satoken@showa.gunma-u.ac.jp027-220-8127

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026